BCL3 is known as a transcription factor associated with the activity of NF‐κB concerning the inflammatory response in pancreatic and biliary tissues.26 However, future researches are required regarding the regulatory possibility of the NF‐κB signalling pathway in ovarian cancer. This evidence concerns the gene NFKB1 and ovarian cancer.